CUSIP 45257U108 · who reports it, how much, and how much it matters to them
22 of the 720 hedge fund managers we track reported shares of Immunome Inc. (Nasdaq: IMNM) on Form 13F for 30 June 2026. Between them they reported USD 198m. The largest position belongs to Redmile Group, at USD 104m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Redmile Group10 funds on PPLI.com | USD 104m | 7.0% |
| 2 | Sofinnova Investments1 fund on PPLI.com | USD 36m | 1.9% |
| 3 | Marshall Wace LLP84 funds on PPLI.com | USD 11m | 0.0% |
| 4 | Rock Springs Capital Management2 funds on PPLI.com | USD 7.4m | 0.4% |
| 5 | Atom Investors1 fund on PPLI.com | USD 6.3m | 0.6% |
| 6 | Atika Capital Management3 funds on PPLI.com | USD 5.6m | 0.4% |
| 7 | Renaissance Technologies13 funds on PPLI.com | USD 5.3m | 0.0% |
| 8 | Citadel Advisors32 funds on PPLI.com | USD 4.7m | 0.0% |
| 9 | Burkehill Global Management5 funds on PPLI.com | USD 4.2m | 0.2% |
| 10 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 2.8m | 0.0% |
| 11 | Sio Capital Management4 funds on PPLI.com | USD 2.6m | 0.4% |
| 12 | Neo Ivy Capital Management1 fund on PPLI.com | USD 1.7m | 0.4% |
| 13 | Edgestream Partners5 funds on PPLI.com | USD 1.5m | 0.0% |
| 14 | Baker Bros. Advisors2 funds on PPLI.com | USD 1.2m | 0.0% |
| 15 | Magnetar Financial93 funds on PPLI.com | USD 691,000 | 0.0% |
| 16 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 564,000 | 0.0% |
| 17 | Brevan Howard Capital Management39 funds on PPLI.com | USD 535,000 | 0.0% |
| 18 | Two Sigma Investments35 funds on PPLI.com | USD 507,000 | 0.0% |
| 19 | Boothbay Fund Management2 funds on PPLI.com | USD 390,000 | 0.0% |
| 20 | Jain Global1 fund on PPLI.com | USD 378,000 | 0.0% |
| 21 | Capstone Investment Advisors25 funds on PPLI.com | USD 299,000 | 0.0% |
| 22 | Aquatic Capital Management3 funds on PPLI.com | USD 86,031 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Redmile Group | USD 104m | 7.0% |
| 2 | Sofinnova Investments | USD 36m | 1.9% |
| 3 | Atom Investors | USD 6.3m | 0.6% |
| 4 | Sio Capital Management | USD 2.6m | 0.4% |
| 5 | Neo Ivy Capital Management | USD 1.7m | 0.4% |
| 6 | Atika Capital Management | USD 5.6m | 0.4% |
| 7 | Rock Springs Capital Management | USD 7.4m | 0.4% |
| 8 | Burkehill Global Management | USD 4.2m | 0.2% |
| 9 | Edgestream Partners | USD 1.5m | 0.0% |
| 10 | Campbell & Company Investment Adviser | USD 564,000 | 0.0% |
Immunome Inc. trades under the symbol IMNM on the Nasdaq. Its CUSIP, the code used on Form 13F, is 45257U108.
22 of the 720 hedge fund managers PPLI.com tracks reported Immunome Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Redmile Group (USD 104m), Sofinnova Investments (USD 36m), Marshall Wace LLP (USD 11m), Rock Springs Capital Management (USD 7.4m) and Atom Investors (USD 6.3m).
22 managers in our coverage reported it, and between them they run 399 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Redmile Group, where the position was 7.0% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Immunome Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.